CTRI/2023/06/054056尚未招募2 期
METRONOMIC CAPECITABINE FOR MAINTENANCE IN NON METASTATIC TRIPLE NEGATIVE BREAST CANCER [TNBC] AFTER STANDARD TREATMENT
Maharishi Markandeshwar Institute of Medical Sciences and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 25 -75 yrs.
- •2. Karnofsky performance status more than 70
- •3. Completed planned standard therapy (Surgery, Chemotherapy- neoadjuvant/ adjuvant,
- •Radiotherapy)
- •4. Proven to be non metastatic after standard treatment also by imaging with whole body
- •PET-CT before starting tab. Capecitabine.
- •5. No other synchronous malignancy
排除标准
- •1. Age <25 yrs and >75 yrs.
- •2. With history of treatment for Breast cancer or for any other Malignancy
- •3. Deranged liver and kidney functions
- •4. Deranged coagulation profile [bleeding time, clotting time, PT-INR]
- •5. Known hypersensitivity to capacitabine or 5-Flourouracil
- •6. Metastatic Disease at presentation or after completion of standard therapy
研究者
相似试验
进行中（未招募）
不适用
Mantainance low dose oral navelbine in patients with non small cell lung cancer previously treated with chemotherapy containing platinum: a best supportive care study: MA.NI.LA trial.Advanced non small cell lung cancer (NSCLC) (Inoperable Stage III - IV).MedDRA version: 14.1Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001103-21-ITISTITUTO NAZIONALE PER LA CURA TUMORI
进行中（未招募）
不适用
TILITY OF THE ocolytict MAINTENANCE TREATMENT IN THE MANAGEMENT OF THE THREAT OF PREMATUREThreat Preterm laborEUCTR2012-002547-15-ESInstituto de Investigacion Sanitaria La Fe
已完成
不适用
Phase II study of pemetrexed maintenance with or without bevacizumab after a first line treatment chemotherapy with bevacizumab-carboplatin-pemetrexed in patients with advanced, metastatic or recurrent non-squamous non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000010002Internal Medicine 2, Hamamatsu University School of Medicine.110
已完成
不适用
Examination of effectiveness on maintenance of continuing treatment and treatment effect in treatment of refractory mood disorder of transcranial direct current stimulation (tDCS)Mood disorderJPRN-UMIN000024953Department of Neuropsychiatry,Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan100
已完成
不适用
The investigation for maintenance therapy by mesalazine enema after remission induction by budesonide form enema in patients with ulcerative colitis: Multicenter randomized controlled studyulcerative colitisJPRN-UMIN000034016Hyogo College of Medicine84